{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:19:37Z","timestamp":1791908377537,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.intimp.2026.117061","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:02:26Z","timestamp":1782259346000},"page":"117061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["PTPN1 synergistically promotes hepatocellular carcinoma progression by inhibiting the expression of STAT5 in CD8+ T cells and enhancing the activity of the PI3K-AKT pathway"],"prefix":"10.1016","volume":"185","author":[{"given":"Zhao","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingfang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doudou","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenqi","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaobin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2026.117061_bb0005","doi-asserted-by":"crossref","DOI":"10.5306\/wjco.v16.i4.102735","article-title":"Pretreatment radiomic imaging features combined with immunological indicators to predict targeted combination immunotherapy response in advanced hepatocellular carcinoma","volume":"16","author":"Zhang","year":"2025","journal-title":"World J Clin Oncol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117061_bb0010","article-title":"Hepatocellular carcinoma: Epidemiology, diagnosis and treatment","volume":"7","author":"Mauro","year":"2025","journal-title":"JHEP Rep."},{"key":"10.1016\/j.intimp.2026.117061_bb0015","doi-asserted-by":"crossref","first-page":"1623670","DOI":"10.3389\/fonc.2025.1623670","article-title":"Differentiation of AFP-negative hepatocellular carcinoma from other intrahepatic malignant lesions by a noninvasive predictive model based on Sonazoid contrast-enhanced ultrasound","volume":"15","author":"Zhang","year":"2025","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117061_bb0020","doi-asserted-by":"crossref","DOI":"10.70352\/scrj.cr.25-0429","article-title":"Hepatocellular carcinoma confined to the bile duct without hepatic mass or jaundice: a case report","volume":"11","author":"Aoki","year":"2025","journal-title":"Surg. Case Rep."},{"key":"10.1016\/j.intimp.2026.117061_bb0025","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bbi.2024.02.008","article-title":"Overexpression of forebrain PTP1B leads to synaptic and cognitive impairments in obesity","volume":"117","author":"Ge","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.intimp.2026.117061_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117791","article-title":"Insights into PTP1B inhibitors as antidiabetic agents: current research and future perspectives","volume":"295","author":"Haider","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.intimp.2026.117061_bb0035","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/CAD.0000000000001724","article-title":"9-hexadecenoic acid inhibits the aggressiveness of gastric cancer via targeting PTPN1\/FTH1 signaling","volume":"36","author":"Wang","year":"2025","journal-title":"Anticancer Drugs"},{"issue":"9","key":"10.1016\/j.intimp.2026.117061_bb0040","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1016\/j.apsb.2025.06.028","article-title":"Activatable PROTAC nanoassembly for photodynamic PTP1B proteolysis enhances glioblastoma immunotherapy","volume":"15","author":"Jang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"15","key":"10.1016\/j.intimp.2026.117061_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157434","article-title":"Resveratrol impairs insulin signaling in hepatic cells via activation of PKC and PTP1B pathways","volume":"26","author":"Hern\u00e1ndez-Gonz\u00e1lez","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117061_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s13065-025-01544-9","article-title":"Watercress-derived glucosinolates as potential allosteric PTP1B inhibitors: a dual in silico and in vitro study on insulin signaling modulation","volume":"19","author":"Ahmed","year":"2025","journal-title":"BMC Chem."},{"issue":"1","key":"10.1016\/j.intimp.2026.117061_bb0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00125-024-06288-0","article-title":"Circulating extracellular vesicle-carried PTP1B and PP2A phosphatases as regulators of insulin resistance","volume":"68","author":"Ali","year":"2025","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.intimp.2026.117061_bb0060","first-page":"1","article-title":"Comprehensive bioinformatics analysis reveals PTPN1 (PTP1B) is a promising immunotherapy target associated with T cell function for liver cancer","author":"Zhu","year":"2023","journal-title":"J. Healthc. Eng."},{"issue":"2","key":"10.1016\/j.intimp.2026.117061_bb0065","first-page":"717","article-title":"PTPN1 promotes the progression of glioma by activating the MAPK\/ERK and PI3K\/AKT pathways and is associated with poor patient survival","volume":"42","author":"Jin","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.intimp.2026.117061_bb0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12935-019-0958-z","article-title":"Long non-coding RNA UCA1 promotes breast cancer by upregulating PTP1B expression via inhibiting miR-206","volume":"19","author":"Li","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"2","key":"10.1016\/j.intimp.2026.117061_bb0075","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.bbrc.2018.06.094","article-title":"PTP1B promotes the malignancy of ovarian cancer cells in a JNK-dependent mechanism","volume":"503","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.intimp.2026.117061_bb0080","doi-asserted-by":"crossref","DOI":"10.3892\/or.2024.8808","article-title":"The combination of a PTP1B inhibitor, TNFR2 blocker, and PD-1 antibody suppresses the progression of non-small cell lung cancer tumors by enhancing immunocompetence","volume":"52","author":"Gui","year":"2024","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2026.117061_bb0085","article-title":"PROX1 expression in resected non-small cell lung cancer: immunohistochemical profile and clinicopathological correlates","volume":"13","author":"Ntikoudi","year":"2025","journal-title":"Med. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117061_bb0090","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13045-021-01036-y","article-title":"Clonal evolution in liver cancer at single-cell and single-variant resolution","volume":"14","author":"Su","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"13","key":"10.1016\/j.intimp.2026.117061_bb0095","article-title":"Protein tyrosine phosphatase 1B (PTP1B): a comprehensive review of its role in pathogenesis of human diseases","volume":"25","author":"K","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2026.117061_bb0100","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.canlet.2015.01.020","article-title":"PTP1B promotes cell proliferation and metastasis through activating src and ERK1\/2 in non-small cell lung cancer","volume":"359","author":"Liu","year":"2015","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.intimp.2026.117061_bb0105","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10585-022-10168-5","article-title":"PLXDC2 enhances invadopodium formation to promote invasion and metastasis of gastric cancer cells via interacting with PTP1B","volume":"39","author":"Wu","year":"2022","journal-title":"Clin. Exp. Metastasis"},{"issue":"1","key":"10.1016\/j.intimp.2026.117061_bb0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1158\/2159-8290.CD-24-0306","article-title":"Zongertinib (BI 1810631), an irreversible HER2 TKI, spares EGFR signaling and improves therapeutic response in preclinical models and patients with HER2-driven cancers","volume":"15","author":"Wilding","year":"2025","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.intimp.2026.117061_bb0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/0115748928279007231130070056","article-title":"Increased SLC7A3 expression inhibits tumor cell proliferation and predicts a Favorable prognosis in breast Cancer","volume":"20","author":"He","year":"2025","journal-title":"Recent Pat. Anticancer Drug Discov."},{"issue":"11","key":"10.1016\/j.intimp.2026.117061_bb0120","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s12032-025-03070-z","article-title":"Retraction note to: Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer","volume":"42","author":"Yin","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.intimp.2026.117061_bb0125","doi-asserted-by":"crossref","first-page":"1053856","DOI":"10.3389\/fimmu.2022.1053856","article-title":"Multi-omics analyses of tumor-associated immune-infiltrating cells with the novel immune checkpoint protein tyrosine phosphatase 1B (PTP1B) in extracellular matrix of brain-lower-grade-glioma (LGG) and uveal-melanoma (UVM)","volume":"13","author":"Bai","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117061_bb0130","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1158\/2159-8290.CD-21-0694","article-title":"PTP1B is an intracellular checkpoint that limits T-cell and CAR T-cell antitumor immunity","volume":"12","author":"Wiede","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2026.117061_bb0135","doi-asserted-by":"crossref","DOI":"10.1093\/burnst\/tkaf053","article-title":"The role of glucose metabolism in wound healing: an overview","volume":"13","author":"Zhang","year":"2025","journal-title":"Burns Trauma"},{"key":"10.1016\/j.intimp.2026.117061_bb0140","doi-asserted-by":"crossref","first-page":"1704061","DOI":"10.3389\/fonc.2025.1704061","article-title":"Editorial: interplay of immunity and ECM in cancer","volume":"15","author":"Fejza","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2026.117061_bb0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.matbio.2025.04.002","article-title":"ECM, integrins, and DDRs: a nexus of cancer progression, therapy, and future directions","volume":"138","author":"Al Azim","year":"2025","journal-title":"Matrix Biol."},{"key":"10.1016\/j.intimp.2026.117061_bb0150","article-title":"Matrix-bound EGF promotes malignant phenotypes of breast cancer organoids in the biomimetic ECM of alginate","volume":"32","author":"Chen","year":"2025","journal-title":"Mater Today Bio."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:39:44Z","timestamp":1784230784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926009070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S1567576926009070"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117061","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PTPN1 synergistically promotes hepatocellular carcinoma progression by inhibiting the expression of STAT5 in CD8+ T cells and enhancing the activity of the PI3K-AKT pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117061"}}